Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.22.1
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Accounts payable:    
Clinical and regulatory expenses $ 699 $ 534
Professional fees 817 477
Selling expenses 671 932
Manufacturing costs 283 378
Board member compensation 283 136
Other vendors 120 262
Total accounts payable 2,873 2,719
Accrued interest payable, related parties 142 91
Accrued interest payable 618 579
Accrued expenses:    
Payroll expenses 877 1,097
Government rebates and other rebates 4,461 4,371
Other accrued expenses 747 332
Total accrued expenses 6,085 5,800
Total accounts payable and accrued expenses $ 9,718 $ 9,189